FDA Approves Medtronic’s CGM System for Type 2 Diabetes

“With predictive alerts and the Sugar.IQ assistant, the Guardian Connect system enables people to proactively manage their diabetes, so they can focus on living their life, not constantly worrying about their glucose levels,” Brüls said.

The company’s most recent FDA indication came for a device for patients with type 1 diabetes: the Guardian Sensor 3 CGM system, which the FDA allowed patients to wear on their upper arm in combination with a hybrid closed-loop system, in a decision made last month.

Medtronic intends to make the Guardian Connect system available in the first quarter of Medtronic’s 2019 fiscal year.

Leave a Reply

Your email address will not be published. Required fields are marked *